AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Aug 30, 2012
30071_dirs_2012-08-30_c469d153-363b-43ee-bfbb-ec5dd16c3c1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-28
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-28 | ResMed Common Stock | M | 25000 | $23.095 | Acquired | 123683.878 | Direct |
| 2012-08-28 | ResMed Common Stock | S | 25000 | $37.50 | Disposed | 98683.878 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-28 | ResMed Common Stock Options | $23.095 | M | 25000 | Disposed | 2013-11-10 | ResMed Common Stock (25000) | Direct |
Footnotes
F1: Represents date grant first became exercisable. Options vest 1/4 annually.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29